Screener
Bruker BRKR Bsi Biospin — Cost Of Segment Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept brkr:CostOfSegmentRevenue.
The source filing: Bruker’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335226
| Line item | Three Months Ended June 30, 2026 / BSI Bio Spin | Three Months Ended June 30, 2026 / BSI CALID | Three Months Ended June 30, 2026 / BSI NANO | Three Months Ended June 30, 2026 / BEST | Three Months Ended June 30, 2026 / Total | Three Months Ended June 30, 2025 / BSI Bio Spin | Three Months Ended June 30, 2025 / BSI CALID | Three Months Ended June 30, 2025 / BSI NANO | Three Months Ended June 30, 2025 / BEST | Three Months Ended June 30, 2025 / Total |
|---|---|---|---|---|---|---|---|---|---|---|
| Intersegment revenue | — | — | — | 3.0 | 3.0 | — | — | — | 2.1 | 2.1 |
| Total segment revenue | $195.7 | $310.3 | $261.3 | $74.2 | $841.5 | $195.3 | $285.8 | $252.1 | $66.3 | $799.5 |
| Segment expenses: | ||||||||||
| Cost of revenue | $94.1 | $126.1 | $123.7 | $59.8 | $403.7 | $108.1 | $125.6 | $125.6 | $52.3 | $411.6 |
| Selling, general and administrative | 38.4 | 79.3 | 68.6 | 5.8 | 192.1 | 40.9 | 76.9 | 72.7 | 5.7 | 196.2 |
| Research and development | 21.5 | 32.6 | 39.2 | 1.0 | 94.3 | 23.2 | 30.0 | 44.4 | 1.1 | 98.7 |
| Segment operating income | $41.7 | $72.3 | $29.8 | $7.6 | $151.4 | $23.1 | $53.3 | $9.4 | $7.2 | $93.0 |
| Reconciliation of Total operating income: |
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Bruker's bsi biospin — cost of segment revenue?
- Bruker (BRKR) reported bsi biospin — cost of segment revenue of $94.1M in Q2 2026.
- How has Bruker's bsi biospin — cost of segment revenue changed year-over-year?
- Bruker's bsi biospin — cost of segment revenue decreased by 13.0% year-over-year, from $108.1M to $94.1M.
- What is the long-term trend for Bruker's bsi biospin — cost of segment revenue?
- Over 3 years (2022 to 2025), Bruker's bsi biospin — cost of segment revenue has grown at a 13.3% compound annual growth rate (CAGR), from $320.6M to $465.9M.
- What does bsi biospin — cost of segment revenue mean?
- This represents the direct costs associated with producing and delivering the goods and services sold by the BioSpin segment. It includes raw materials, direct labor, and manufacturing overhead directly attributable to the segment's operations. Monitoring this helps evaluate the segment's production efficiency and gross margin potential.
Ask your AI about Bruker's bsi biospin — cost of segment revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude